Stay updated on CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.

Latest updates to the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page
- Check2 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0; the study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedA site-wide notice announces changes to NIH websites and says that “Super Intelligence” is being used in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check16 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the page displaying a 403 error.SummaryDifference0.2%

- Check23 days agoChange DetectedThe site revision marker in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe 403 Forbidden block was removed, returning the Study Details page to its normal layout. This enables access to the study information for NCT05187182.SummaryDifference0.5%

- Check44 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with an access-restricted notice and a basic footer. This indicates that the study record is presently inaccessible.SummaryDifference21%

Stay in the know with updates to CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.